Rezolute (RZLT) Invested Capital (2011 - 2022)

Rezolute (RZLT) reported Invested Capital of $15.7 million for Q1 2022, little changed sequentially from $15.7 million in Q4 2021.

Rezolute (RZLT) Invested Capital (2011 - 2022) Analysis & Trends

Rezolute (RZLT) has 8 years of Invested Capital data on file, last reported at $15.7 million in Q1 2022.

For the quarter ending Q1 2022, Invested Capital changed N/A year-over-year to $15.7 million; the trailing twelve-month figure through Dec 2022 stood at $15.7 million (down 66.66% YoY), and the FY2021 full-year result was $15.7 million, changed N/A from the prior year.
Invested Capital steadied at $15.7 million in Q1 2022, from $15.7 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $15.7 million in Q2 2021 to a low of $15.7 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	110.96 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	116.14 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Rezolute	518.12 Mn	518.12 Mn	-	-

Download Data